MBBS FRACP DHIthSc
MEDICAL LEAD CANCER SERVICES CAHLN
HEAD OF CLINICAL ONCOLOGY RESEARCH AT THE QUEEN ELIZABETH
HOSPITAL, WOODVILLE, AUSTRALIA
About Our Speaker
Clinical Cancer Research at The Queen Elizabeth Hospital in Adelaide. His major clinical interest is in
treatment of patients with gastrointestinal cancer, and he is currently involved in an extensive gastrointestinal clinical trial program. He is a professor at the University of Adelaide and Colorectal Cancer Stream leader for the South Australian Health and Medical Research Institute, and leads the gastrointestinal translational and research laboratory at the Basil Hetzel Institute. He chairs the current national NHMRC Cancer Council Colorectal Guidelines committee which led to the recently published update. He is also a visiting/honorary professor at the University of Sydney and the University of Antwerp.
Maximizing benefit for patients in 3L mCRC, clinical case discussion
Therapeutic sequencing and 3L treatment selection in mCRC.
Finding the ideal sequence in 3L mCRC – Experience from daily practice
The importance of patients selection and treatment sequencing to optimize mCRC outcomes.